| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.10. | Germany's Tubulis raises €308m for ADC pipeline | ||
| 15.10. | J&J streamlines with plan to hive off orthopaedics unit | ||
| 15.10. | Can new Tukysa data drop unlock its sales potential? | ||
| 14.10. | $600m round will help Kailera push obesity drug into phase 3 | ||
| 14.10. | Investor seeks sale of Novavax after poor COVID jab sales | ||
| 14.10. | FDA clears Roche, Lilly Alzheimer's blood test | ||
| 14.10. | Boehringer, Click DTx for schizophrenia clears pivotal trial | ||
| 14.10. | Astellas suffers pancreatic cancer failure with Vyloy | ||
| 13.10. | WHO sounds alarm over rising tide of antibiotic resistance | ||
| 13.10. | UCB drug for rare disease TK2d boosts survival | ||
| 13.10. | Data shows survival gain with UCB drug for rare disease TK2d | ||
| 13.10. | Kelun gets world-first approval for TROP2 ADC | ||
| 13.10. | Chaos as layoffs start to hit HHS agencies | ||
| 13.10. | AstraZeneca joins Pfizer in MFN pricing deal with US | ||
| 10.10. | BMS builds in 'in vivo' cell therapy with $1.5bn Orbital buy | ||
| 10.10. | UK funds 17 projects on World Mental Health Day | ||
| 10.10. | AZ starts work on Virginia plant in $50bn US investment plan | ||
| 10.10. | TrumpRx, BlinkRX, GoodRx - what's going on in DTC sales? | ||
| 10.10. | Soufflé's tasty $200m raise, and other biofinancings | ||
| 09.10. | UK and US agencies team up for medtech, AI regulation | ||
| 09.10. | In monster MASH takeover deal, Novo buys Akero for $4.7bn | ||
| 09.10. | NHS could pay more for medicines under new plan | ||
| 09.10. | Amazon to launch drug vending machines at One Medical sites | ||
| 09.10. | Regeneron's Libtayo stakes out new territory in skin cancer | ||
| 08.10. | NICE finalises support for CSL's HAE therapy Andembry |